Director, APAC Evidence & Access Strategy – Ion

Primary Function of Position
This role leads the clinical, economic, and access-focused evidence strategy for the Ion Business Unit across priority Asia Pacific (APAC) markets. You own the regional strategy that shows how Ion improves patient outcomes, care pathways, and health-system efficiency – and you use that evidence to unlock and scale access, reimbursement, and adoption.
This role will work closely with APAC Commercial, Country GMs, Clinical Affairs, Product Management, Clinical Development Engineering, Medical Office, and Clinical Marketing, and collaborate with the Global Access Value and Economics(GAVE) team.

Key Responsibilities
 Set the APAC evidence & access strategy
Define a 3–5 year clinical and economic evidence roadmap for Ion in APAC, linked to clear access, reimbursement, and adoption milestones in priority markets.
 Design and deliver high-impact evidence
Lead design and prioritization of clinical and economic studies (clinical outcomes, RWE, cost effectiveness, budget impact, pathway/resource use) that answer payer, HTA, hospital, and clinical decision-maker questions.
 Translate data into value stories
Turn evidence into locally relevant value propositions, dossiers, slide decks, tools, and decision aids for payers, HTA bodies, hospital value committees, and clinical champions.
 Develop access pathways
Develop APAC access plans (eg. HTA routes, innovation funding, direct payer contracting, hospital funding logic, coding/reimbursement context), and supply the Ion-specific evidence and analytics needed for submissions and negotiations, without owning pricing or commercial terms.
 Act as the regional Ion “go-to” for evidence & access
Work with cross-functional teams as the regional Ion expert, and liaison to global headquarters.
 Shape the external environment
Build and maintain senior relationships with KOLs, professional societies, payers, HTA agencies, and hospital decision-makers; selectively engage in consultations, guidelines, registries, and collaborative studies that move adoption barriers.
 Lead teams, vendors, and budgets
Provide leadership to direct reports and matrixed contributors. Select and manage HEOR/HTA/MA agencies, CROs, and data vendors. Own or co-own budgets and focus spend on initiatives with measurable access and adoption impact.
 Track impact and course-correct
Define and monitor KPIs (e.g., HTA decisions, time to funding, procedure volume, contribution of evidence programs). Use policy, competitive, and clinical-trend insights to refine the APAC strategy over time.

Qualifications
Required
 Advanced clinical, scientific, or health-economics degree (e.g., MD, PharmD, PhD, MPH, MSc in life sciences, health economics, public health, or related field).
 10+ years’ progressive experience in clinical and economic evidence, HEOR, and/or market access for medical devices or interventional technologies, with significant responsibility across multiple APAC markets.
 Proven track record contributing to successful reimbursement or funding outcomes in APAC (e.g., HTA submissions, innovation / pilot funding, coding or reimbursement changes, hospital funding decisions).
 Strong understanding of APAC healthcare systems, payer and HTA decision-making, and hospital financing/procurement.
 Ability to connect product and procedural details to outcomes, operational impact, and economic value – and to communicate that succinctly to senior clinical and non-clinical stakeholders.
 Demonstrated success leading regional or multi-country initiatives and influencing senior leaders in a matrix environment.
 Excellent written and verbal communication in English; proficiency in at least one major APAC language (e.g., Japanese, Korean, or Mandarin) strongly preferred.

Preferred
 Experience in robotic or minimally invasive technologies, interventional pulmonology, thoracic oncology, or related fields.
 Prior people-leadership experience (direct reports and/or substantial matrix leadership).
 Willingness and ability to travel across APAC and occasionally internationally.

当社は、法令に従い、全ての応募者について、その適性と能力のみを基準として公正に採用選考を行います。